Potential coronavirus treatment granted rare disease status

The pharmaceutical giant that makes a promising coronavirus drug has registered it as a rare disease treatment with U.S. regulators, a status that can potentially be worth millions in tax breaks and competition-free sales. Experts who have studied the so-called “orphan drug” program say the company's request — and the Food and Drug Administration's decision to grant it — seem inappropriate given the rapidly expanding threat of the viral outbreak. The FDA granted the status on Monday, according to the agency's website.

from Yahoo News - Latest News & Headlines https://ift.tt/3bt9VqP
via IFTTT